Pioneers in cancer care
The Aktis Oncology team is pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumors.
Aktis Leadership Team
R&D Leaders
Aktis Board of Directors
Jim Carmichael, MD
OBSERVER
View Bio
Maurizio Mariani, MD, PhD
OBSERVER
View Bio
Alex Tkachenko, PhD
OBSERVER
View Bio
Kevin Raidy
OBSERVER
View Bio
Investors













Our investor syndicate includes other undisclosed investors.
Join us
Join a team dedicated to discovering and developing transformative therapies that put solid cancers into remission. View Careers
